Subscribe To
This fixed income etf is poised to outperform equities during rising rates
With interest rates expected to continue to rise through the end of the year, many investors are worried about the potential impact on their investmen...
April 6, 2022, 5:19 pm
Cypher metaverse completes final tranche of previously announced non-brokered private placement raising proceeds of $178,500
Cypher Metaverse Inc (CSE:CODE, OTCQB:BKLLF) - formerly Codebase Ventures Inc - said it has completed its previously announced non-brokered private pl...
March 23, 2022, 7:15 am
Leggett & platt's financial performance since 1999 suggests it will keep marching on
Leggett & Platt's Financial Performance Since 1999 Suggests It Will Keep Marching On...
March 22, 2022, 12:22 pm
Amazon makes a comeback after stock split. but how long can it sustain the momentum?
Amazon.com Inc. (NASDAQ:AMZN) traded up more than 6% on Thursday after announcing its fourth stock split since the 1997 IPO. The stock split, the firs...
March 10, 2022, 5:41 pm
Amazon announced a 20-for-1 stock split. here's what that means and how it will impact investors
Amazon on Wednesday unveiled plans for its first stock split since September 1999....
March 10, 2022, 3:07 pm
Empower clinics appoints healthcare executive anthony tomasello to its board
Empower Clinics Inc. (CSE:CBDT, OTCQB:EPWCF), an integrated healthcare company, has announced the appointment of health executive Anthony Tomasello to...
February 22, 2022, 8:13 am
Empower clinics appoints healthcare executive anthony tomasello to its board
Empower Clinics Inc. (CSE:CBDT, OTCQB:EPWCF), an integrated healthcare company, has announced the appointment of health executive Anthony Tomasello to...
February 22, 2022, 8:13 am
Empower clinics appoints healthcare executive anthony tomasello to its board
Empower Clinics Inc. (CSE:CBDT, OTCQB:EPWCF), an integrated healthcare company, has announced the appointment of health executive Anthony Tomasello to...
February 22, 2022, 8:13 am
Netease to report fourth quarter and fiscal year 2021 financial results on february 24
HANGZHOU, China, Feb. 8, 2022 /PRNewswire/ -- NetEase, Inc. (NASDAQ: NTES and HKEX: 9999, "NetEase" or ...
February 8, 2022, 3:30 am
Netease to report fourth quarter and fiscal year 2021 financial results on february 24
HANGZHOU, China, Feb. 8, 2022 /PRNewswire/ -- NetEase, Inc. (NASDAQ: NTES and HKEX: 9999, "NetEase" or ...
February 8, 2022, 3:30 am
Netease to report fourth quarter and fiscal year 2021 financial results on february 24
HANGZHOU, China, Feb. 8, 2022 /PRNewswire/ -- NetEase, Inc. (NASDAQ: NTES and HKEX: 9999, "NetEase" or ...
February 8, 2022, 3:30 am
Xenon pharmaceuticals announces closing of $345 million public offering including full exercise of the underwriters' option to purchase additional shares
BURNABY, British Columbia, Oct. 08, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, tod...
October 8, 2021, 2:15 pm
Xenon pharmaceuticals announces closing of $345 million public offering including full exercise of the underwriters' option to purchase additional shares
BURNABY, British Columbia, Oct. 08, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, tod...
October 8, 2021, 2:15 pm
Xenon pharmaceuticals announces closing of $345 million public offering including full exercise of the underwriters' option to purchase additional shares
BURNABY, British Columbia, Oct. 08, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, tod...
October 8, 2021, 2:15 pm
Xenon pharmaceuticals announces pricing of $300.0 million public offering
BURNABY, British Columbia, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, tod...
October 5, 2021, 9:54 pm
Xenon pharmaceuticals announces pricing of $300.0 million public offering
BURNABY, British Columbia, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, tod...
October 5, 2021, 9:54 pm
Xenon pharmaceuticals announces pricing of $300.0 million public offering
BURNABY, British Columbia, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, tod...
October 5, 2021, 9:54 pm
Xenon pharmaceuticals announces pricing of $300.0 million public offering
BURNABY, British Columbia, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, tod...
October 5, 2021, 9:54 pm
Xenon pharmaceuticals announces pricing of $300.0 million public offering
BURNABY, British Columbia, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, tod...
October 5, 2021, 9:54 pm